Microparticles from apoptotic monocytes induce transient platelet recruitment and tissue factor expression by cultured human vascular endothelial cells via a redox-sensitive mechanism

Thrombosis and Haemostasis

Volumn 98, Issue 4, 2007, Pages 831-837

  Essayagh, Sanah ^a   Xuereb, Jean Marie ^a   Terrisse, Anne Dominique ^a   Tellier Cirioni, Lise ^a   Pipy, Bernard ^b   Sié, Pierre ^a,c  

^a INSERM   (France)

^b UNIVERSITÉ DE TOULOUSE   (France)

^c CHU PURPAN   (France)

Author keywords

Endothelial cells; Microparticles; Monocytes; Oxidative stress

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE P38; REACTIVE OXYGEN METABOLITE; SUPEROXIDE; THROMBOPLASTIN; VON WILLEBRAND FACTOR;

APOPTOSIS; ARTICLE; CELL CULTURE; CELL INTERACTION; CELL SURFACE; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; MONOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; THROMBOCYTE; THROMBOSIS; UPREGULATION; VASCULAR ENDOTHELIUM;

APOPTOSIS; BLOOD PLATELETS; CELL MEMBRANE; ENDOTHELIAL CELLS; HUMANS; MONOCYTES; OXIDATION-REDUCTION; OXIDATIVE STRESS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; REACTIVE OXYGEN SPECIES; THROMBOPLASTIN; UP-REGULATION; VON WILLEBRAND FACTOR;

EID: 35048852484     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH07-02-0082     Document Type: Article

References (32)

1. Piccin A, Murphy WG, Smith OP. Circulating microparticles: pathophysiology and clinical implications. Blood Rev 2007; 21: 157-171.
2. Morel O, Toti F, Hugel B, et al. Procoagulant micro-particles: disrupting the vascular homeostasis equation? Arterioscler Thromb Vasc Biol 2006; 26: 2594-2604.
3. Leroyer AS, Isobe H, Lesèche G, et al. Cellular origins and thrombogenic activity of microparticles isolated from human atherosclerotic plaques. J Am Coll Cardiol 2007; 49: 772-777.
4. Brill A, Dashevsky O, Rivo J, et al. Platelet-derived microparticles induce angiogenesis and stimulate post-ischemic revascularization. Cardiovasc Res 2005; 67: 30-38.
5. Brodsky SV, Zhang F, Nasjletti A, et al. Endothelium-derived microparticles impair endothelial function in vitro. Am J Physiol Heart Circ Physiol 2004; 286: H1910-H1915.
6. Mesri M, Altieri DC. Leukocyte microparticles stimulate endothelial cell cytokine release and tissue factor induction in a JNK1 signaling pathway. J Biol Chem 1999; 274: 23111-23118.
7. Martin S, Tesse A, Hugel B, et al. Shed membrane particles from T lymphocytes impair endothelial function and regulate endothelial protein expression. Circulation 2004; 109: 1653-1659.
8. Essayagh S, Brisset AC, Terrisse AD, et al. Microparticles from apoptotic vascular smooth muscle cells induce endothelial dysfunction, a phenomenon prevented by beta3-integrin antagonists. Thromb Haemost 2005; 94: 853-858.
9. Omoto S, Nomura S, Shouzu A, et al. Detection of monocyte-derived microparticles in patients with Type II diabetes mellitus. Diabetologia 2002; 45: 550-555.
10. Ogata N, Nomura S, Shouzu A, et al. Elevation of monocyte-derived microparticles in patients with diabetic retinopathy. Diabetes Res Clin Pract 2006; 73: 241-248.
11. Shet AS, Aras O, Gupta K, et al. Sickle blood contains tissue factor-positive microparticles derived from endothelial cells and monocytes. Blood 2003; 102: 2678-2683.
12. Chironi G, Simon A, Hugel B, et al. Circulating leukocyte-derived microparticles predict subclinical atherosclerosis burden in asymptomatic subjects. Arterioscler Thromb Vasc Biol 2006; 26: 2775-2780.
13. Bennett MR. Reactive oxygen species and death: oxidative DNA damage in atherosclerosis. Circ Res 2001; 88: 648-650.
14. McCarthy NJ, Bennett MR. The regulation of vascular smooth muscle cell apoptosis. Cardiovasc Res 2000; 45: 747-755.
15. Kolowos W, Gaipl US, Sheriff A, et al. Microparticles shed from different antigen-presenting cells display an individual pattern of surface molecules and a distinct potential of allogenic T-cell activation. Scand J Immunol 2005; 61: 226-233.
16. del Conde I, Shrimpton CN, Thiagarajan P, et al. Tissue-factor-bearing microvesicles arise from lipid rafts and fuse with activated platelets to initiate coagulation. Blood 2006; 106: 1604-1611.
17. Brisset AC, Terrisse AD, Dupouy D, et al. Shedding of active tissue factor by aortic smooth muscle cells (SMCs) undergoing apoptosis. Thromb Haemost 2003; 90: 511-518.
18. Cadroy Y, Gaspin D, Dupouy D, et al. Heparin reverses the procoagulant properties of stimulated endothelial cells. Thromb Haemost 1996; 75: 190-195.
19. Ghrib F, Brisset AC, Dupouy D, et al. The expression of tissue factor and tissue factor pathway inhibitor in aortic smooth muscle cells is up-regulated in synthetic compared to contractile phenotype. Thromb Haemost 2002; 87: 1051-1056.
20. Cai H, Harrison DG. Endothelial dydsfunction in cardiovascular diseases. The role of oxidant stress. Circ Res 2000; 87: 840-844.
21. Sata M, Suhara T, Walsh K. Vascular endothelial cells and smooth muscle cells differ in expression of Fas and Fas ligand and in sensitivity to Fas ligand-induced cell death: implications for vascular disease and therapy. Arterioscler Thromb Vasc Biol2OOO; 20: 309-316.
22. Jacobi J, Kristal B, Chezar J, et al. Exogenous superoxide mediates pro-oxidative, proinflammatory, and procoagulatory changes in primary endothelial cell cultures. Free Radic Biol Med 2005; 39: 1238-1248.
23. Janiszewski M, Do Carmo AO, Pedro MA, et al. Platelet-derived exosomes of septic individuals possess proapoptotic NAD(P)H oxidase activity: A novel vascular redox pathway. Crit Care Med 2004; 32: 818-825.
24. Irani K. Oxidant signaling in vascular cell growth, death, and survival: a review of the roles of reactive oxygen species in smooth muscle and endothelial cell mitogenic and apoptotic signaling. Circ Res 2000; 87: 179-183.
25. Vischer UM, Jornot L, Wollheim CB, et al. Reactive oxygen intermediates induce regulated secretion of von Willebrand factor from cultured human vascular endothelial cells. Blood 1995; 85: 3164-3172.
26. Bombeli T, Schwartz BR, Harlan JM. Endothelial cells undergoing apoptosis become proadhesive for nonactivated platelets. Blood 1999; 93: 3831-3838.
27. Wu G, Essex DW, Meloni FJ, et al. Human endothelial cells in culture and in vivo express on their surface all four components of the glycoprotein Ib/IX/V complex. Blood 1997; 90: 2660-2669.
28. Tan L, Kowalska MA, Romo GM, et al. Identification and characterization of endothelial glycoprotein Ib using viper venom proteins modulating cell adhesion. Blood 1999; 93: 2605-2616.
29. Wu SQ, Aird WC. Thrombin, TNF-alpha, and LPS exert overlapping but nonidentical effects on gene expression in endothelial cells and vascular smooth muscle cells. Am J Physiol Heart Circ Physiol 2005; 289: H873-885.
30. Vega-Ostertag M, Casper K, Swerlick R, et al. Involvement of p38 MAPK in the up-regulation of tissue factor on endothelial cells by antiphospholipid antibodies. Arthritis Rheum 2005; 52: 1545-1554.
31. Szotowski B, Antoniak S, Goldin-Lang, et al. Antixoidative treatment inhibits the release of thrombogenic tissue factor from irradiation-and cytokin-induced endothelial cells. Cardiovasc Res 2007; 73: 806-812.
32. Simoncini S, Sapet C, Camoin-Jau L, et al. Role of reactive oxygen species and p38 MARK in the induction of the pro-adhesive endothelial state mediated by IgG from patients with anti-phospholipid syndrome. Int Immunol 2005; 17: 489-500.